MedDataX Logo

Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women

NCT ID: NCT01621347

Last Updated: 2015-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

26 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-03-31

Study Completion Date

2012-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare adherence to antiretroviral therapy during pregnancy and postpartum, and to record adherence barriers and facilitators.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Data of all consecutive pregnant women included in the adherence enhancing program of the Pharmacy, Department of ambulatory care \& community medicine, are collected. In this program, adherence is measured and enhanced by electronic monitoring, pill count, motivational interviewing and interdisciplinary collaboration. Electronic monitoring data are collected during pregnancy and postpartum, and compared. Barriers and facilitators are collected using interview's marks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infection Pregnancy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

HIV Pregnancy Postpartum Women Medication Adherence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant Women
* HIV-positive
* Antiretroviral medication delivered in electronical monitors

Exclusion Criteria

* Monitored period during pregnancy \< 1 month
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Vaudois

OTHER

Sponsor Role collaborator

Swiss HIV Cohort Study

NETWORK

Sponsor Role collaborator

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marie Schneider

Pharmacist, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marie-Paule Schneider, PhD

Role: STUDY_CHAIR

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

Aurélie Gertsch, PhD-Student

Role: PRINCIPAL_INVESTIGATOR

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

Olivier Bugnon, Professor

Role: STUDY_CHAIR

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

Odile Michel, Student

Role: PRINCIPAL_INVESTIGATOR

Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland

Matthias Cavassini, M.D

Role: STUDY_CHAIR

Centre Hosppitalier Universitaire Vaudois

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Policlinique Médicale Universitaire

Lausanne, Canton of Vaud, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

48/12

Identifier Type: -

Identifier Source: org_study_id